Inactive Instrument
Aoxing Pharmaceutical Company, Inc. Stock Other OTC
Stocks
AOXG
US03740A1060
Professional & Business Education
OTC Markets Traded| Market Cap | 23.62M 20.46M 19.07M 17.54M 33.12M 2.25B 33.49M 224M 87.97M 1.12B 88.73M 86.77M 3.72B | P/E 2015 |
20.1x | P/E 2016 | 23.2x |
|---|---|---|---|---|---|
| Enterprise Value | 42.18M 36.54M 34.06M 31.32M 59.14M 4.01B 59.8M 400M 157M 2.01B 158M 155M 6.65B | EV / Sales 2015 |
5.77x | EV / Sales 2016 | 2.11x |
| Free-Float |
100% | Yield 2015 * |
-
| Yield 2016 | - |
| 1 day | -20.71% |
| Manager | Title | Age | Since |
|---|---|---|---|
Chun Fai Lo
CEO | Chief Executive Officer | - | - |
Po Chim
DFI | Director of Finance/CFO | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -20.71% | -19.80% | - | - | 1.33M | |
| -33.38% | -28.93% | -14.81% | +263.60% | 2.33B | |
| -7.66% | +4.33% | -26.94% | -52.31% | 2.15B | |
| +0.31% | -0.18% | - | - | 1.83B | |
| -8.77% | -7.83% | +58.04% | +349.71% | 1.36B | |
| -1.48% | -8.93% | -48.94% | +31.36% | 1.24B | |
| -0.43% | -1.00% | +326.78% | +907.35% | 1.1B | |
| -4.02% | +0.23% | +55.75% | +41.01% | 1.04B | |
| +6.24% | +25.32% | +36.56% | +85.87% | 947M | |
| -6.65% | +50.41% | +67.69% | -21.73% | 699M | |
| Average | -7.65% | +3.44% | +56.77% | +200.61% | 1.41B | |
| Weighted average by Cap. | -8.73% | +2.18% | +39.19% | +195.63% |
| 2015 | 2016 | |
|---|---|---|
| Net sales | 25.48M 22.07M 20.57M 18.92M 35.72M 2.42B 36.12M 242M 94.88M 1.21B 95.7M 93.59M 4.02B | 32.33M 28M 26.1M 24.01M 45.32M 3.07B 45.83M 307M 120M 1.54B 121M 119M 5.09B |
| Net income | 5.49M 4.76M 4.44M 4.08M 7.7M 522M 7.79M 52.13M 20.46M 261M 20.64M 20.18M 866M | 2.06M 1.79M 1.66M 1.53M 2.89M 196M 2.92M 19.56M 7.68M 98.07M 7.74M 7.57M 325M |
| Net Debt | 24.8M 21.48M 20.03M 18.42M 34.77M 2.36B 35.16M 235M 92.36M 1.18B 93.16M 91.11M 3.91B | 18.56M 16.07M 14.98M 13.78M 26.02M 1.76B 26.31M 176M 69.11M 883M 69.71M 68.17M 2.92B |
Employees
-
